Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I 2023-05-25 09:51
BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 2023-05-24 16:14
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S. 2023-05-18 20:50
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
Fresh2 Reports Fiscal Year 2022 Annual Financial Results 2023-05-17 04:15
WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients 2023-05-16 16:00
LG Chem Targets Sixfold Sales Growth in Battery Materials to KRW 30 Trillion by 2030 2023-05-16 09:34
CMUH Smart Medicine System Assisted the ARDS Specialist Team Successfully Reversed the Patient's Critical Condition 2023-05-15 20:30
Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE) 2023-05-15 19:00
1 49 50 51 52 53 165